Form 1 Neurologic and Psychiatric Effects of SARS-CoV2 Meeting

Neurologic and Psychiatric Effects of SARS-CoV-2 Infection

 

HOMEPAGE

MEETING GOALS

 

The National Institute of Mental Health (Division of AIDS Research), National Institute of Neurological Disorders and Stroke and National Institute on Aging are organizing a virtual meeting entitled “Neurologic and Psychiatric Effects of SARS-CoV-2 Infection” to be held on July 14-15, 2021. There is emerging data that in as high as 30 percent of COVID-19 patients neurologic and psychiatric symptoms are observed. COVID-19 patients experience ischemic strokes, cerebral hemorrhages, encephalitis, prolonged unconsciousness and altered mental states (psychosis, delirium). Anxiety and post-traumatic stress disorders (PTSD) symptoms are also seen in these patients. A majority of patients also develop loss of smell and taste, myalgias and fatigue or malaise.

Many patients also experience Post-Acute Sequelae of SARS-CoV-2 infection (PASC). These include prolonged symptoms of fatigue, impairment of memory, concentration disorder, headache, pain, insomnia, anxiety, PTSD, and depression. Pathologically there is controversy about detection of SARS-CoV-2 in the brain and current thinking is that the virus does not infect the brain. However, there is strong evidence for microvascular disease, inflammation, and immune infiltration in the brain.

This meeting will examine emerging data related to neurologic and psychiatric complications of SARS-CoV-2 infection and possible interactions with other CNS infections such as HIV. A panel will be convened to discuss future research gaps and priorities particularly with regard to long term neurologic and psychiatric complications in relation to post-acute sequelae of SARS-CoV-2 (PASC).

Please register today! (link this to the registration page)

 

Meeting Organizing Committee

Serena Spudich, MD

Professor of Neurology, Yale University

Avindra Nath, MD

Clinical Director, National Institute of Neurological Disorders and Stroke

Eliezer Masliah, MD

Director, Division of Neuroscience, National Institute on Aging

Jeymohan Joseph, PhD

Chief, HIV Neuropathogenesis and Therapeutics Branch

National Institute of Mental Health

REGISTRATION

OMB# 0925-0740; Exp date 7/31/2022

Public reporting burden for this collection of information is estimated to average 1 minute per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate, or any other aspect of this collection of information, including suggestions for reducing this burden, to: NIH Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, Maryland 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

Registration is free and open until July 12, 2020 at 5:00PM, ET.

CEU’s are not being offered for this meeting.

After you register, you will receive a confirmation email from (insert available Bizzell email address). If you have any questions regarding your registration, please contact us via email at (insert available Bizzell email address).

First Name:

Last Name:

Organization:

Job Title:

Highest Degree Received:

Email Address: